Analysis of data from 537 US hospitals found that ceftolozane-tazobactam and ceftazidime-avibactam are the most frequently ...

AbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for ...

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

A groundbreaking $50 million investment has been announced to combat the growing threat of antimicrobial resistance (AMR) in ...

Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled ...

The Gates Foundation, Novo Nordisk Foundation and Wellcome have announced the launch of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), a $50 million investment that will focus on ...

This guide includes an overview of practices for the prevention and management of sexually transmitted and blood-borne infections (STBBI) by healthcare professionals practicing in public health or ...

Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

The following is a summary of “Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram ...